Beactica Therapeutics AB
Share:
Subscribe:
news.cision.com
/
Beactica Therapeutics AB
/
Beactica Therapeutics appoints Jarl Ulf Jungnelius M.D. to its Board of Directors as it advances towards clinical-stage activities
/
Ulf Jungnelius
Ulf Jungnelius
Mon, Jun 19, 2023 09:00 CET
Low resolution
Medium resolution
Original resolution
Subscribe